US4475196A
(en)
|
1981-03-06 |
1984-10-02 |
Zor Clair G |
Instrument for locating faults in aircraft passenger reading light and attendant call control system
|
US4447233A
(en)
|
1981-04-10 |
1984-05-08 |
Parker-Hannifin Corporation |
Medication infusion pump
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
US4486194A
(en)
|
1983-06-08 |
1984-12-04 |
James Ferrara |
Therapeutic device for administering medicaments through the skin
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
US5374548A
(en)
|
1986-05-02 |
1994-12-20 |
Genentech, Inc. |
Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
|
MX9203291A
(es)
|
1985-06-26 |
1992-08-01 |
Liposome Co Inc |
Metodo para acoplamiento de liposomas.
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
US4954617A
(en)
|
1986-07-07 |
1990-09-04 |
Trustees Of Dartmouth College |
Monoclonal antibodies to FC receptors for immunoglobulin G on human mononuclear phagocytes
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
US4881175A
(en)
|
1986-09-02 |
1989-11-14 |
Genex Corporation |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
EP0307434B2
(fr)
|
1987-03-18 |
1998-07-29 |
Scotgen Biopharmaceuticals, Inc. |
Anticorps alteres
|
US5013653A
(en)
|
1987-03-20 |
1991-05-07 |
Creative Biomolecules, Inc. |
Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
|
ATE120761T1
(de)
|
1987-05-21 |
1995-04-15 |
Creative Biomolecules Inc |
Multifunktionelle proteine mit vorbestimmter zielsetzung.
|
US5132405A
(en)
|
1987-05-21 |
1992-07-21 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
US5091513A
(en)
|
1987-05-21 |
1992-02-25 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
GB8809129D0
(en)
|
1988-04-18 |
1988-05-18 |
Celltech Ltd |
Recombinant dna methods vectors and host cells
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
US6020145A
(en)
|
1989-06-30 |
2000-02-01 |
Bristol-Myers Squibb Company |
Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
GB9019812D0
(en)
|
1990-09-11 |
1990-10-24 |
Scotgen Ltd |
Novel antibodies for treatment and prevention of infection in animals and man
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
GB9223377D0
(en)
|
1992-11-04 |
1992-12-23 |
Medarex Inc |
Humanized antibodies to fc receptors for immunoglobulin on human mononuclear phagocytes
|
US5589579A
(en)
|
1994-07-19 |
1996-12-31 |
Cytoclonal Pharmaceutics, Inc. |
Gene sequence and probe for a marker of non-small cell lung carinoma
|
WO2000073454A1
(fr)
|
1999-06-02 |
2000-12-07 |
Genentech, Inc. |
Polypeptides transmembranaires secretes et acides nucleiques codants pour ceux-ci
|
WO2001016318A2
(fr)
|
1999-09-01 |
2001-03-08 |
Genentech, Inc. |
Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci
|
WO2000015796A2
(fr)
|
1998-09-16 |
2000-03-23 |
Genentech, Inc. |
Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
US5677139A
(en)
|
1995-04-21 |
1997-10-14 |
President And Fellows Of Harvard College |
In vitro differentiation of CD34+ progenitor cells into T lymphocytes
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
KR19990077146A
(ko)
|
1996-01-11 |
1999-10-25 |
길리스 스티브 |
유방암의 치료 및 진단용 조성물 및 방법
|
WO2000073348A2
(fr)
|
1999-06-02 |
2000-12-07 |
Genentech, Inc. |
Procedes et compositions visant a inhiber la proliferation des cellules cancereuses
|
WO2000075327A1
(fr)
|
1999-06-02 |
2000-12-14 |
Genentech, Inc. |
Methodes et compositions d'inhibition de croissance cellulaire neoplasique
|
WO2000053756A2
(fr)
|
1999-03-08 |
2000-09-14 |
Genentech, Inc. |
Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
US20070224663A1
(en)
|
1997-03-07 |
2007-09-27 |
Human Genome Sciences, Inc. |
Human Secreted Proteins
|
US7368531B2
(en)
|
1997-03-07 |
2008-05-06 |
Human Genome Sciences, Inc. |
Human secreted proteins
|
US7411051B2
(en)
|
1997-03-07 |
2008-08-12 |
Human Genome Sciences, Inc. |
Antibodies to HDPPA04 polypeptide
|
WO2000078961A1
(fr)
|
1999-06-23 |
2000-12-28 |
Genentech, Inc. |
Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides
|
US20030022298A1
(en)
|
1997-09-15 |
2003-01-30 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20030073129A1
(en)
|
1998-09-01 |
2003-04-17 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20020127584A1
(en)
|
1997-09-18 |
2002-09-12 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20030166104A1
(en)
|
1997-09-18 |
2003-09-04 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20030027272A1
(en)
|
1997-09-18 |
2003-02-06 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20030170794A1
(en)
|
1997-09-18 |
2003-09-11 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20050196832A1
(en)
|
1997-09-18 |
2005-09-08 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20030008352A1
(en)
|
1997-09-18 |
2003-01-09 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7160985B2
(en)
|
1997-10-29 |
2007-01-09 |
Genentech, Inc. |
Pro180 polypeptide
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
US20030040471A1
(en)
|
1998-04-29 |
2003-02-27 |
Watson James D. |
Compositions isolated from skin cells and methods for their use
|
US20030022835A1
(en)
|
1998-04-29 |
2003-01-30 |
Genesis Research And Development Corporation Limited |
Compositions isolated from skin cells and methods for their use
|
JP3428441B2
(ja)
|
1998-05-15 |
2003-07-22 |
エーザイ株式会社 |
タイトジャンクション構成膜蛋白質クローディンファミリー
|
US7319008B2
(en)
|
1998-06-02 |
2008-01-15 |
Genentech, Inc. |
Nucleic acid underexpressed in melanoma
|
US7351543B2
(en)
|
1998-06-02 |
2008-04-01 |
Genentech, Inc. |
Antibodies to a polypeptide encoded by a nucleic acid underexpressed in melanoma
|
EP1084142A4
(fr)
|
1998-06-11 |
2005-01-19 |
Smithkline Beecham Corp |
Recepteur de gpr35a
|
US7339033B2
(en)
|
1998-06-26 |
2008-03-04 |
Genentech, Inc. |
Pro1481
|
CA2347656A1
(fr)
|
1998-08-04 |
2000-02-17 |
Diadexus, Inc. |
Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons
|
US20050181478A1
(en)
|
1998-09-01 |
2005-08-18 |
Baker Kevin P. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
NZ531664A
(en)
|
1998-09-01 |
2005-07-29 |
Genentech Inc |
Pro1317 polypeptides and sequences thereof with homology to the semaphorin B glycoprotein family
|
US20030082626A1
(en)
|
1998-09-01 |
2003-05-01 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7026448B2
(en)
|
1998-09-01 |
2006-04-11 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7375184B2
(en)
|
1998-09-01 |
2008-05-20 |
Genentech, Inc. |
PRO1382 polypeptides
|
WO2000015659A2
(fr)
|
1998-09-16 |
2000-03-23 |
Zymogenetics, Inc. |
Polypeptide stomacal zsig28
|
JP2004500011A
(ja)
*
|
1998-10-06 |
2004-01-08 |
キュラゲン コーポレイション |
新規な分泌タンパク質、およびそれをコードするポリヌクレオチド
|
US7399834B2
(en)
|
1998-10-07 |
2008-07-15 |
Genentech, Inc. |
Anti-PRO1558 antibodies
|
US6235481B1
(en)
|
1998-10-21 |
2001-05-22 |
Arch Development Corporation & Board Of Regents |
Polynucleotides encoding calpain 10
|
US20030190669A1
(en)
|
1998-12-30 |
2003-10-09 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7026449B2
(en)
|
1999-01-05 |
2006-04-11 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7507404B2
(en)
|
1999-03-08 |
2009-03-24 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
JP2003531811A
(ja)
|
1999-03-08 |
2003-10-28 |
ジェネンテック・インコーポレーテッド |
血管形成及び心臓血管新生の促進又は阻害
|
KR100504305B1
(ko)
|
1999-03-23 |
2005-07-28 |
제넨테크, 인크. |
분비 및 막횡단 폴리펩티드 및 이를 코딩하는 핵산
|
CA2383592A1
(fr)
|
1999-03-31 |
2000-10-05 |
Curagen Corporation |
Acides nucleiques comprenant des phases de lecture ouverte codant des polypeptides; orfx
|
US20080286821A1
(en)
|
1999-05-14 |
2008-11-20 |
Eaton Dan L |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU2215300A
(en)
|
1999-06-02 |
2000-12-28 |
Genentech Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
JP2003529324A
(ja)
|
1999-06-15 |
2003-10-07 |
ジェネンテック・インコーポレーテッド |
分泌及び膜貫通ポリペプチドとそれをコードする核酸
|
AU2883900A
(en)
|
1999-07-07 |
2001-01-30 |
Genentech Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU1205901A
(en)
|
1999-10-14 |
2001-04-23 |
Board Of Trustees Of The University Of Arkansas, The |
Tumor antigen derived gene-16 (tadg-16): a novel extracellular serine protease and uses thereof
|
EP2228446A1
(fr)
|
1999-12-01 |
2010-09-15 |
Genentech, Inc. |
Polypeptides secrétés et transmembranaires et acides nucléiques codant pour ceux-ci
|
US6380362B1
(en)
|
1999-12-23 |
2002-04-30 |
Genesis Research & Development Corporation Ltd. |
Polynucleotides, polypeptides expressed by the polynucleotides and methods for their use
|
JP4280444B2
(ja)
|
2000-01-06 |
2009-06-17 |
ジェネンテック・インコーポレーテッド |
腫瘍性細胞成長阻害のための組成物及び方法
|
CA2395398A1
(fr)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Acides nucleiques, proteines, et anticorps
|
AU2001237958A1
(en)
|
2000-01-31 |
2001-08-07 |
Human Genome Sciences, Inc. |
22 human secreted proteins
|
WO2001055326A2
(fr)
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Acides nucleiques, proteines et anticorps
|
US20030050231A1
(en)
|
2000-01-31 |
2003-03-13 |
Rosen Craig A. |
Nucleic acids, proteins, and antibodies
|
CA2401070A1
(fr)
|
2000-02-22 |
2001-08-30 |
Corixa Corporation |
Compositions et methodes destinees au diagnostic et a la therapie du mesotheliome malin
|
AU6802801A
(en)
|
2000-03-01 |
2001-09-24 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU4592601A
(en)
|
2000-03-21 |
2001-10-03 |
Millennium Predictive Medicine |
Novel genes, compositions, kits, and method for identification, assessment, prevention, and therapy of ovarian cancer
|
US6436703B1
(en)
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
EP1276849A4
(fr)
|
2000-04-12 |
2004-06-09 |
Human Genome Sciences Inc |
Proteines fusionnees a de l'albumine
|
AU2001260847A1
(en)
|
2000-05-24 |
2001-12-03 |
Genesis Research And Development Corporation Limited |
Compositions isolated from skin cells and methods for their use
|
WO2002002621A2
(fr)
|
2000-06-30 |
2002-01-10 |
Zymogenetics, Inc. |
Proteines secretees mammaliennes
|
EA013564B1
(ru)
|
2000-08-03 |
2010-06-30 |
Терапеутик Хьюман Поликлоналз Инк. |
Гуманизированный иммуноглобулин и содержащая его фармацевтическая композиция
|
WO2002014500A2
(fr)
|
2000-08-16 |
2002-02-21 |
Chiron Corporation |
Genes humains et produits d'expression genique
|
JP2004520814A
(ja)
|
2000-08-28 |
2004-07-15 |
ディアデクサス インコーポレーテッド |
肺特異的遺伝子に関する組成物および方法
|
EP1315743B1
(fr)
|
2000-09-08 |
2012-11-07 |
Merck Sharp & Dohme Corp. |
Genes mammaliens, reactifs et methodes associes
|
WO2002022885A1
(fr)
|
2000-09-18 |
2002-03-21 |
Thomas Jefferson University |
Compositions et procedes permettant l'identification et le ciblage des cellules cancereuses de l'estomac et de l'oesophage
|
JP3523245B1
(ja)
|
2000-11-30 |
2004-04-26 |
メダレックス,インコーポレーテッド |
ヒト抗体作製用トランスジェニック染色体導入齧歯動物
|
WO2002061087A2
(fr)
|
2000-12-19 |
2002-08-08 |
Lifespan Biosciences, Inc. |
Peptides antigeniques destines a des recepteurs couples a la proteine g (gpcr), anticorps s'y rapportant, et systeme d'identification desdits peptides antigeniques
|
AU2002255478A1
(en)
|
2001-01-10 |
2002-09-12 |
Pe Corporation (Ny) |
Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
JP2004535776A
(ja)
|
2001-01-29 |
2004-12-02 |
フェイズ − 1 モレキュラー トクシコロジー、インコーポレイテッド |
ラット毒性関連遺伝子及びその使用
|
JP2004526441A
(ja)
|
2001-02-26 |
2004-09-02 |
アリーナ・フアーマシユーチカルズ・インコーポレーテツド |
内因性および非内因性型ヒトgタンパク質共役受容体
|
US20030152939A1
(en)
|
2001-04-09 |
2003-08-14 |
Glennda Smithson |
Novel secreted proteins and polynucleotides encoding them
|
US20060084794A1
(en)
|
2001-04-12 |
2006-04-20 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
JP2003000249A
(ja)
|
2001-05-10 |
2003-01-07 |
Daiichi Fine Chemical Co Ltd |
クローディンによるMT−MMPsを介したproMMP−2活性化
|
US20030108890A1
(en)
|
2001-05-30 |
2003-06-12 |
Baranova Anna Vjacheslavovna |
In silico screening for phenotype-associated expressed sequences
|
JP2004533840A
(ja)
|
2001-07-06 |
2004-11-11 |
ジェネンテック・インコーポレーテッド |
ファージディスプレイによるpdzドメインリガンド
|
CA2457424A1
(fr)
|
2001-08-03 |
2003-02-20 |
Arbor Vita Corporation |
Interactions moleculaires dans les cellules
|
US20030023042A1
(en)
|
2001-12-06 |
2003-01-30 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20040002587A1
(en)
|
2002-02-20 |
2004-01-01 |
Watkins Jeffry D. |
Fc region variants
|
CA2379661A1
(fr)
|
2002-03-28 |
2003-09-28 |
Kursad Turksen |
Systeme d'administration paracellulaire de medicament
|
AU2003240495A1
(en)
|
2002-06-04 |
2003-12-19 |
Incyte Corporation |
Diagnostics markers for lung cancer
|
WO2004029629A1
(fr)
*
|
2002-09-27 |
2004-04-08 |
Janssen Pharmaceutica N.V. |
Anticorps monoclonaux beta-amyloide n-11 tronques, compositions, methodes et utilisations
|
BRPI0314814C1
(pt)
|
2002-09-27 |
2021-07-27 |
Xencor Inc |
anticorpo compreendendo uma variante de fc
|
SI1558648T1
(sl)
|
2002-10-17 |
2012-05-31 |
Genmab As |
Človeška monoklonalna protitelesa proti CD
|
CA2505479A1
(fr)
|
2002-11-14 |
2004-06-03 |
Arbor Vita Corporation |
Interactions moleculaires dans des neurones
|
DE10254601A1
(de)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
EP1430902A1
(fr)
|
2002-12-20 |
2004-06-23 |
Mondobiotech Laboratories Anstalt |
Composition pharmaceutique comprenant l'interferon gamma avec diagnostic moléculaire pour un meilleur traitment de l'asthme
|
EP2368578A1
(fr)
|
2003-01-09 |
2011-09-28 |
Macrogenics, Inc. |
Identification et ingénierie d'anticorps avec régions FC de variante et procédés d'utilisation associés
|
US20050181375A1
(en)
|
2003-01-10 |
2005-08-18 |
Natasha Aziz |
Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer
|
EP1639090A4
(fr)
|
2003-06-09 |
2008-04-16 |
Univ Michigan |
Compositions et methodes de traitement et de diagnostic du cancer
|
US20060240441A1
(en)
|
2003-10-03 |
2006-10-26 |
Bayer Pharmaceuticals Corporation |
Gene expression profiles and methods of use
|
DE10354601B3
(de)
|
2003-11-21 |
2005-06-23 |
Chiropro Gmbh |
Gelenkprothese für Fingerglieder
|
WO2005052182A2
(fr)
|
2003-11-26 |
2005-06-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Procede d'analyse de contenu de proteine a membrane plasmique de cellules
|
EP1709084A4
(fr)
|
2003-12-23 |
2008-05-28 |
Nono Inc |
Polypeptides pour la modulation de la liaison des proteines du canal de recepteur de potentiel transitoire et proteines associees au recepteur de potentiel transitoire
|
WO2005076939A2
(fr)
|
2004-02-09 |
2005-08-25 |
University Of Kentucky Research Foundation |
Test et procede de diagnostic et de traitement de la maladie d'alzheimer
|
EP1732582A2
(fr)
|
2004-02-26 |
2006-12-20 |
Ohio University |
Diagnostic d'hyperinsulinemie et du diabete de type ii et protection contre lesdits etats pathologique grace aux genes exprimes de fa on differentielle dans les cellules musculaires
|
US20050255041A1
(en)
|
2004-05-13 |
2005-11-17 |
Arius Research, Inc. |
Cancerous disease modifying antibodies
|
DE102004024617A1
(de)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
WO2005114221A2
(fr)
|
2004-05-21 |
2005-12-01 |
The Institute For Systems Biology |
Compositions et methodes de quantification de glycoproteines du serum
|
WO2006023121A1
(fr)
|
2004-07-27 |
2006-03-02 |
Ohio University |
Diagnostic d'hyperinsulinemie et de diabete de type ii et protection contre ceux-ci a base de genes differentiellement exprimes dans le tissu adipeux blanc (13)
|
DE102004042822A1
(de)
|
2004-08-31 |
2006-03-16 |
Technische Universität Dresden |
Verbindungen und Methoden zur Behandlung, Diagnose und Prognose bei Pankreaserkrankungen
|
FR2876705B1
(fr)
|
2004-10-19 |
2008-12-12 |
Biomerieux Sa |
Procede pour le diagnostic d'une intolerance a l'aspirine
|
US20070072175A1
(en)
|
2005-05-13 |
2007-03-29 |
Biogen Idec Ma Inc. |
Nucleotide array containing polynucleotide probes complementary to, or fragments of, cynomolgus monkey genes and the use thereof
|
ATE549624T1
(de)
|
2005-07-01 |
2012-03-15 |
Arbor Vita Corp |
Verfahren und zusammensetzungen zur diagnose und behandlung von grippe
|
AU2006280321A1
(en)
|
2005-08-15 |
2007-02-22 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
WO2007027867A2
(fr)
*
|
2005-08-31 |
2007-03-08 |
Cell Signaling Technology, Inc. |
Reactifs de detection de phosporylation proteinique dans des voies de signalisation de carcinome
|
BRPI0616211A2
(pt)
|
2005-09-19 |
2011-06-14 |
Veridex Llc |
mÉtodos para o diagnàstico de cÂncer pancreÁtico
|
US20070099251A1
(en)
|
2005-10-17 |
2007-05-03 |
Institute For Systems Biology |
Tissue-and serum-derived glycoproteins and methods of their use
|
EP1790664A1
(fr)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Anticorps monoclonaux contre claudin-18 pour le traitement du cancer
|
AU2007254005B2
(en)
*
|
2006-02-10 |
2012-11-29 |
Genentech, Inc. |
Anti-FGF19 antibodies and methods using same
|
CN101448856A
(zh)
|
2006-03-29 |
2009-06-03 |
健泰科生物技术公司 |
肿瘤的诊断和治疗
|
WO2008013948A2
(fr)
|
2006-07-27 |
2008-01-31 |
Cell Signaling Technology, Inc. |
Sites de phosphorylation de tyrosines
|
US8586006B2
(en)
|
2006-08-09 |
2013-11-19 |
Institute For Systems Biology |
Organ-specific proteins and methods of their use
|
US8450057B2
(en)
|
2006-08-14 |
2013-05-28 |
The Brigham And Women's Hospital, Inc. |
Diagnostic tests using gene expression ratios
|
US20090258442A1
(en)
*
|
2006-08-31 |
2009-10-15 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
BRPI0716944A2
(pt)
|
2006-09-19 |
2013-09-17 |
Novartis Ag |
biomarcadores de modulaÇço alvo, eficÁcia, diagnàstico, e/ou prognàstico para inibidores de raf
|
JP2010505897A
(ja)
|
2006-10-11 |
2010-02-25 |
マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ |
インフルエンザターゲット
|
WO2008073303A2
(fr)
|
2006-12-07 |
2008-06-19 |
Switchgear Genomics |
Éléments de régulation transcriptionnelle de voies biologiques, outils, et procédés
|
EP2104734A2
(fr)
|
2006-12-08 |
2009-09-30 |
Asuragen, INC. |
Gènes et voies génétiques régulés par le mir-20 en tant que cibles en vue d'une intervention thérapeutique
|
MX2009008307A
(es)
|
2007-02-01 |
2009-08-25 |
Veridex Llc |
Metodos y materiales para identificar el origen de un carcinoma de origen primario desconocido.
|
EP1983002A3
(fr)
*
|
2007-04-19 |
2009-03-11 |
Peter Hornbeck |
Sites de phosphorylation à tyrosine et anticorps spécifiques
|
EP1997832A1
(fr)
*
|
2007-05-29 |
2008-12-03 |
Ganymed Pharmaceuticals AG |
Anticorps monoclonaux contre la claudine-18 pour le traitement contre le cancer
|
AU2008261951A1
(en)
|
2007-06-08 |
2008-12-18 |
Asuragen, Inc. |
miR-34 regulated genes and pathways as targets for therapeutic intervention
|
WO2009015050A2
(fr)
|
2007-07-20 |
2009-01-29 |
The Gov. Of The U.S.A. As Represented By The Secretary Of The Department Of Health & Human Services |
Profil d'expression génique pour prédire la survie d'une patiente atteinte d'un cancer des ovaires
|
WO2009035497A2
(fr)
|
2007-08-08 |
2009-03-19 |
Savidge Tor C |
Modifications de cystéine associées à une maladie et leur utilisation
|
EP2036987A1
(fr)
|
2007-09-17 |
2009-03-18 |
Siemens Healthcare Diagnostics GmbH |
Marqueurs moléculaires pour le contenu de cellules de tumeurs dans des échantillons de tissus
|
WO2009047362A2
(fr)
|
2007-10-12 |
2009-04-16 |
The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin |
Procédé pour ouvrir des jonctions serrées
|
US8563515B2
(en)
|
2007-11-19 |
2013-10-22 |
The Regents Of The University Of Colorado, A Body Corporate |
Tight junction protein modulators and uses thereof
|
KR20110018930A
(ko)
|
2008-06-02 |
2011-02-24 |
엔에스에이비피 파운데이션, 인크. |
암 치료에서 예후적 및 예견적 마커의 확인 및 용도
|
WO2009155609A1
(fr)
|
2008-06-20 |
2009-12-23 |
Oklahoma Medical Research Foundation |
PEPTIDES IMMUNOGÈNES DE LA MÉMAPSINE 2 β-SECRÉTASE ET PROCÉDÉS D'UTILISATION
|
WO2010046889A1
(fr)
|
2008-10-23 |
2010-04-29 |
Quark Pharmaceuticals, Inc. |
Procédés de distribution d'arnsi à des cellules de moelle osseuse et leurs utilisations
|
CN101381524A
(zh)
|
2008-10-24 |
2009-03-11 |
南开大学 |
单层氧化石墨与水溶性高分子增强复合材料
|
US20110286916A1
(en)
|
2008-11-20 |
2011-11-24 |
Jose Miguel Aste-Amezaga |
Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use
|
GB0904957D0
(en)
|
2009-03-23 |
2009-05-06 |
Univ Erasmus Medical Ct |
Tumour gene profile
|
WO2010120526A2
(fr)
|
2009-03-31 |
2010-10-21 |
Emory University |
Procédés et systèmes destinés au dépistage et au diagnostic de la méthylation de l'adn associée aux troubles du spectre autistique
|
CN101584860A
(zh)
*
|
2009-04-27 |
2009-11-25 |
西安杰诺瓦生物科技有限公司 |
重组人Claudin18.2肿瘤疫苗及其制备方法
|
CA2776228A1
(fr)
|
2009-10-01 |
2011-04-07 |
Chipdx Llc |
Systeme et procede de classification de patients
|
EP2507397A4
(fr)
|
2009-12-01 |
2013-05-01 |
Compendia Bioscience Inc |
Classification des cancers
|
EP2366709A1
(fr)
|
2010-03-16 |
2011-09-21 |
BioNTech AG |
Vaccination anti-tumeur impliquant une réponse immunitaire humorale contre les protéines endogènes
|
TR201809413T4
(tr)
*
|
2010-03-16 |
2018-07-23 |
Biontech Protein Therapeutics Gmbh |
Self-protein cldn18.2 ye karşı bir humoral immün yanıtı içeren tümor aşılama.
|
US8945847B2
(en)
|
2010-05-24 |
2015-02-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and kits for ascertaining biosafety of an agent
|
WO2011154139A2
(fr)
|
2010-06-07 |
2011-12-15 |
Roche Diagnostics Gmbh |
Marqueurs d'expression génique pour la prédiction d'une réponse à un traitement par un médicament anticorps monoclonal inhibant le récepteur de l'interleukine-6
|
US8454385B2
(en)
|
2010-06-22 |
2013-06-04 |
John Mezzalingua Associates, LLC |
Coaxial cable connector with strain relief clamp
|
WO2012070014A2
(fr)
|
2010-11-26 |
2012-05-31 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Identification de nouveaux marqueurs de surface cellulaire pour des cellules progénitrices pancréatiques et des cellules endodermiques définies
|
AU2012206163B2
(en)
|
2011-01-12 |
2013-11-14 |
Morinaga Milk Industry Co., Ltd. |
Method for screening for diet providing production of milk having immunoregulatory action
|
DE102011005235B4
(de)
|
2011-03-08 |
2017-05-24 |
Sirs-Lab Gmbh |
Verfahren zum Identifizieren einer Teilmenge von Polynucleotiden aus einer dem Humangenom entsprechenden Ausgangsmenge von Polynucleotiden zur in vitro Bestimmung eines Schweregrads der Wirtsantwort eines Patienten
|
CA2868398A1
(fr)
|
2012-04-02 |
2013-10-10 |
Moderna Therapeutics, Inc. |
Polynucleotides modifies pour la production de proteines et de peptides cosmetiques
|
WO2013167153A1
(fr)
*
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Anticorps utiles dans le diagnostic du cancer
|
WO2013174404A1
(fr)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
|
WO2013174403A1
(fr)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
|
WO2014025198A2
(fr)
|
2012-08-09 |
2014-02-13 |
주식회사 한독 |
Mutant de lfa3, protéine de fusion dans laquelle des polypeptides spécifiques d'une cible sont connectés au mutant ou à la région de liaison à cd2 de lfa3, et leur utilisation
|
WO2014025199A2
(fr)
|
2012-08-09 |
2014-02-13 |
주식회사 한독 |
Mutant de superantigène issu d'entérotoxine staphylococcique, protéine de fusion dans laquelle des polypeptides spécifiques d'une cible sont connectés au mutant et leur utilisation
|
WO2014031859A2
(fr)
|
2012-08-24 |
2014-02-27 |
University Of Utah Research Foundation |
Compositions et méthodes se rapportant à des biomarqueurs sanguins du cancer du sein
|
US20140073524A1
(en)
|
2012-09-07 |
2014-03-13 |
Institute For Systems Biology |
Markers and methods for detecting posttraumatic stress disorder (ptsd)
|
US9856532B2
(en)
|
2012-09-07 |
2018-01-02 |
Institute For Systems Biology |
Markers and methods for detecting posttraumatic stress disorder (PTSD)
|